drugset / Trial / NCT07324850
A Study of SGB-7342 in Subjects With Obesity or Overweight
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of subcutaneously administered SGB-7342 in adult subjects with obesity and overweight.
Timeline
- Start
- 2026-01-12
- Primary completion
- 2026-10-28
- Completion
- 2027-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SGB-7342 | Unknown | — | Subcutaneous |